News
News
Group Company News
OGT Announces Co-marketing and Distribution Partnership with QIAGEN Digital Insights to Advance NGS Panel Analysis Solutions (OGT)
OGT, a Sysmex Group company, today announced that it has entered into a co-marketing and distribution partnership with QIAGEN Digital Insights, the bioinformatics business of QIAGEN, as part of the global alliance agreement between Sysmex and QIAGEN.
Through this partnership, OGT will offer integrated solutions that combine its SureSeq™ NGS panels1 with QIAGEN Clinical Insight (QCI®) Interpret2, QIAGEN’s advanced analysis software. This combined offering streamlines and enhances the entire workflow—from NGS analysis to variant interpretation and reporting—helping laboratories reduce turnaround times and ultimately contribute to improved patient outcomes. For further details, please refer to OGT’s press release.
▶ OGT News Release, September 18, 2025 (https://www.ogt.com/about-us/news/ogt-and-qiagen-announce-partnership/)
Reference
| August 6, 2024 News Release: Sysmex Expands Strategic Alliance Agreement with QIAGEN in the Field of Genetic Testing https://www.sysmex.co.jp/en/news/2024/240806.html |
Terminology
| 1 | SureSeq™ NGS Panels: | |
| Hybridization-based next-generation sequencing panels developed by OGT, designed for comprehensive detection of tumor-related genetic variants with high sensitivity and accuracy. | ||
| 2 | QIAGEN Clinical Insight Interpret: | |
| A variant interpretation software provided by QIAGEN Digital Insights, combining AI-powered analytics with expert curation to deliver reliable variant classification and reporting for clinical research. |
- The purpose of this news is to communicate our business activities to our stakeholders. It may or may not include information about Sysmex's products or their research and development, but this is not intended for promotion, advertising, or medical advice. The information contained in this press release is current as of the date of the announcement but may be subject to change without prior notice.